Skip to main content
Displaying 212 of 2893 articles.

Kivanç Birsoy named a 2023 Blavatnik National Awards finalist

Birsoy is honored for groundbreaking research uncovering metabolic weaknesses of diseased cells, such as cancer, while shedding light on debilitating mitochondrial diseases and rare genetic disorders.

An immune flaw may cause West Nile virus’s deadliest symptoms

With 40% of encephalitis cases now explained by an autoimmune deficiency, West Nile virus "is by far the best understood human infectious disease in the world. It’s stunning.”

The clearest snapshot of human genomic diversity ever taken

The human reference genome has always been a remarkable but flawed tool. A new "pangenome" aims to correct its oversights and omissions.

Homing in on the genetics of severe COVID in children

A trio of faulty genes fail to put the brakes on the immune system’s all-out assault on SARS-CoV-2, leading to the inflammatory overload characteristic of MIS-C.

How the intestine replaces and repairs itself

A new study suggests that stem cells are able to integrate cues from their surroundings and coordinate their behavior across tissue through networks of vasculature in their close vicinity.

>

Building a human ‘pangenome’ to capture global genomic diversity

The human reference genome, the most widely used resource in human genetics, is getting a major update.

The genetic underpinnings of severe staph infections

A mutated gene may explain why some Staphylococcus aureus infections turn lethal, a finding with significant implications for people living with 5p- syndrome.

Titia de Lange elected to the Royal Society

She receives the honor for elucidating mechanisms of telomere protection and genome maintenance.

Kivanç Birsoy, expert on cancer cell metabolism, is promoted to associate professor 

Birsoy's groundbreaking research has highlighted key nutrients that cancer cells need to survive, while shedding light on debilitating mitochondrial diseases and rare genetic disorders.

The human genome is, at long last, complete

Even after 20 years of upgrades, eight percent of the human genome was still left unsequenced and unstudied. Until now.